國家衛生研究院 NHRI:Item 3990099045/13643

NHRI > National Institute of Infectious Diseases and Vaccinology > Wang-Chou Sung > Periodical Articles > Item 3990099045/13643

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/13643

Title:	Development of a broad-spectrum antiserum against cobra venoms using recombinant three-finger toxins
Authors:	Liu, BS;Jiang, BR;Hu, KC;Liu, CH;Hsieh, WC;Lin, MH;Sung, WC
Contributors:	National Institute of Infectious Diseases and Vaccinology
Abstract:	Three-finger toxins (3FTXs) are the most clinically relevant components in cobra (genus Naja) venoms. Administration of the antivenom is the recommended treatment for the snakebite envenomings, while the efficacy to cross-neutralize the different cobra species is typically limited, which is presumably due to intra-specific variation of the 3FTXs composition in cobra venoms. Targeting the clinically relevant venom components has been considered as an important factor for novel antivenom design. Here, we used the recombinant type of long-chain α-neurotoxins (P01391), short-chain α-neurotoxins (P60770), and cardiotoxin A3 (P60301) to generate a new immunogen formulation and investigated the potency of the resulting antiserum against the venom lethality of three medially important cobras in Asia, including the Thai monocled cobra (Naja kaouthia), the Taiwan cobra (Naja atra), and the Thai spitting cobra (Naja Siamensis) snake species. With the fusion of protein disulfide isomerase and the low-temperature settings, the correct disulfide bonds were built on these recombinant 3FTXs (r3FTXs), which were confirmed by the circular dichroism spectra and tandem mass spectrometry. Immunization with r3FTX was able to induce the specific antibody response to the native 3FTXs in cobra venoms. Furthermore, the horse and rabbit antiserum raised by the r3FTX mixture is able to neutralize the venom lethality of the selected three medically important cobras. Thus, the study demonstrated that the r3FTXs are potential immunogens in the development of novel antivenom with broad neutralization activity for the therapeutic treatment of victims involving cobra snakes in countries.
Date:	2021-08-10
Relation:	Toxins. 2021 Aug 10;13(8):Article number 556.
Link to:	http://dx.doi.org/10.3390/toxins13080556
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2072-6651&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000689987900001
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85112466522
Appears in Collections:	[Wang-Chou Sung] Periodical Articles

Files in This Item:

File	Description	Size	Format
SCP85112466522.pdf		1779Kb	Adobe PDF	179	View/Open

Loading...